F-18 FDG PET/CT in NK/T-Cell Lymphoma that Progressed from Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis

被引：0
作者：
Il-Hyun Kim
Young-Sil An
Su Jin Lee
Joon-Kee Yoon
机构：
[1] Ajou University School of Medicine,Department of Nuclear Medicine & Molecular Imaging
来源：
Nuclear Medicine and Molecular Imaging | 2022年 / 56卷
关键词：
F-18 FDG PET/CT; Hemophagocytic lymphohistiocytosis; Epstein-Barr virus; NK/T-cell lymphoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome involving an uncontrolled immune response with variable triggers. HLH is rare but highly fatal, even with proper treatment; therefore, early recognition and diagnosis are crucial for management. Although the role of F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in HLH is poorly defined, it can provide valuable information on disease status and possible triggers. Herein, we report an F-18 FDG PET/CT study on a case of NK/T-cell lymphoma that progressed from Epstein-Barr virus-associated HLH.
引用
收藏
页码：59 / 62
页数：3
相关论文
共 59 条
  • [1] Jordan MB(2019)Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO) Pediatr Blood Cancer 66 e27929-1516
  • [2] Allen CE(2014)Adult haemophagocytic syndrome Lancet 383 1503-51
  • [3] Greenberg J(2009)Positron emission tomography as a diagnostic tool in infection: present role and future possibilities Semin Nucl Med 39 36-131
  • [4] Henry M(2007)HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 48 124-871
  • [5] Hermiston ML(2020)18-FDG PET/CT findings in hemophagocytic lymphohistiocytosis: a pictorial review J Nucl Med 61 1140 LP - 1140-667
  • [6] Kumar A(2017)Can 18F-FDG PET/CT distinguish the cause of the hemophagocytic lymphohistiocytosis J Nucl Med 58 1096 LP - 1096-475
  • [7] Ramos-Casals M(2016)The significance of pre-therapeutic F-18-FDG PET–CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable J Cancer Res Clin Oncol 142 859-1254
  • [8] Brito-Zeron P(2014)Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis Ann Hematol 93 661-762
  • [9] Lopez-Guillermo A(2016)F-FDG PET/CT for identifying the potential causes and extent of secondary hemophagocytic lymphohistiocytosis Diagn Interv Radiol 22 471-1287
  • [10] Khamashta MA(2016)The role of (18)F-FDG PET/CT in the management of patients with secondary haemophagocytic lymphohistiocytosis Clin Radiol 71 1248-undefined
123456